Balk SP - Search Results

1

LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer.

Li M, Liu M, Han W, Wang Z, Han D, Patalano S, Macoska JA, Balk SP, He HH, Corey E, Gao S, Cai C. Li M, et al. Among authors: balk sp. Cancer Res. 2023 May 15;83(10):1684-1698. doi: 10.1158/0008-5472.CAN-22-2433. Cancer Res. 2023. PMID: 36877164 Free PMC article.

2

Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.

Taplin ME, Bubley GJ, Ko YJ, Small EJ, Upton M, Rajeshkumar B, Balk SP. Taplin ME, et al. Among authors: balk sp. Cancer Res. 1999 Jun 1;59(11):2511-5. Cancer Res. 1999. PMID: 10363963

3

Steroid hormone receptor signaling in cancer.

Cheng S, Balk SP. Cheng S, et al. Among authors: balk sp. Cancer Treat Res. 2003;115:293-318. doi: 10.1007/0-306-48158-8_12. Cancer Treat Res. 2003. PMID: 12613202 Review.

4

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.

Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG, Balk SP. Stanbrough M, et al. Among authors: balk sp. Cancer Res. 2006 Mar 1;66(5):2815-25. doi: 10.1158/0008-5472.CAN-05-4000. Cancer Res. 2006. PMID: 16510604

5

Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.

Xu Y, Chen SY, Ross KN, Balk SP. Xu Y, et al. Among authors: balk sp. Cancer Res. 2006 Aug 1;66(15):7783-92. doi: 10.1158/0008-5472.CAN-05-4472. Cancer Res. 2006. PMID: 16885382

6

SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.

Wang H, McKnight NC, Zhang T, Lu ML, Balk SP, Yuan X. Wang H, et al. Among authors: balk sp. Cancer Res. 2007 Jan 15;67(2):528-36. doi: 10.1158/0008-5472.CAN-06-1672. Cancer Res. 2007. PMID: 17234760

7

Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.

Hodgson MC, Astapova I, Hollenberg AN, Balk SP. Hodgson MC, et al. Among authors: balk sp. Cancer Res. 2007 Sep 1;67(17):8388-95. doi: 10.1158/0008-5472.CAN-07-0617. Cancer Res. 2007. PMID: 17804755

8

SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion.

Wang H, Leav I, Ibaragi S, Wegner M, Hu GF, Lu ML, Balk SP, Yuan X. Wang H, et al. Among authors: balk sp. Cancer Res. 2008 Mar 15;68(6):1625-30. doi: 10.1158/0008-5472.CAN-07-5915. Cancer Res. 2008. PMID: 18339840

9

The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.

Sun T, Wang Q, Balk S, Brown M, Lee GS, Kantoff P. Sun T, et al. Cancer Res. 2009 Apr 15;69(8):3356-63. doi: 10.1158/0008-5472.CAN-08-4112. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351832 Free PMC article.

10

Development of androgen receptor antagonists with promising activity in castration-resistant prostate cancer.

Shen HC, Balk SP. Shen HC, et al. Among authors: balk sp. Cancer Cell. 2009 Jun 2;15(6):461-3. doi: 10.1016/j.ccr.2009.05.005. Cancer Cell. 2009. PMID: 19477425 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters